Company / Depreciation & Amortization
Corcept Therapeutics Incorporated Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$1.1M
FY2025
5-year range
$795.0K / $1.3M
FY2021-FY2025
Trend
+44.5%
vs FY2024
Sector context
#127 of 177
Health Care
What the data says
At $1M, Corcept Therapeutics Incorporated's depreciation & amortization ranks #51 of 177 in the Health Care sector. Depreciation & Amortization returned to growth in FY2025 after 2 years of decline, reaching $1M.
Based on SEC 10-K filings.
$1M in FY2025 with a 5-year CAGR of +17.0%.
Increased from $1M to $1M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -3.0%
- 5-Year CAGR
- +17.0%
- 10-Year CAGR
- -
Sector benchmark
#51 of 177 in Health CareTop 28% of 177This company $1.1M Sector average $204.7M
▼
-99.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +17.0%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 44.5% year-over-year.
- Ranks #127 out of 177 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 3.44 (safe zone, above 2.9 threshold)
- Strong profit margin: 20.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.1M | +44.5% |
| FY2024 | $795.0K | -23.7% |
| FY2023 | $1.0M | -17.2% |
| FY2022 | $1.3M | +17.4% |
| FY2021 | $1.1M | +104.2% |
| FY2020 | $525.0K | +395.3% |
| FY2019 | $106.0K | +21.8% |
| FY2018 | $87.0K | -17.9% |
| FY2017 | $106.0K | -24.8% |
| FY2016 | $141.0K | -9.0% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026